Antiviral Effect of Ephedrine Alkaloids-Free Ephedra Herb Extract against SARS-CoV-2 In Vitro

We report for the first time that ephedrine alkaloids-free Ephedra Herb extract (EFE) directly inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro and that the addition of EFE to the culture medium before viral infection reduces virus titers in the cultu...

Full description

Bibliographic Details
Main Authors: Masashi Uema, Masashi Hyuga, Kenzo Yonemitsu, Sumiko Hyuga, Yoshiaki Amakura, Nahoko Uchiyama, Kazushige Mizoguchi, Hiroshi Odaguchi, Yukihiro Goda
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Microorganisms
Subjects:
Online Access:https://www.mdpi.com/2076-2607/11/2/534
_version_ 1797619150473920512
author Masashi Uema
Masashi Hyuga
Kenzo Yonemitsu
Sumiko Hyuga
Yoshiaki Amakura
Nahoko Uchiyama
Kazushige Mizoguchi
Hiroshi Odaguchi
Yukihiro Goda
author_facet Masashi Uema
Masashi Hyuga
Kenzo Yonemitsu
Sumiko Hyuga
Yoshiaki Amakura
Nahoko Uchiyama
Kazushige Mizoguchi
Hiroshi Odaguchi
Yukihiro Goda
author_sort Masashi Uema
collection DOAJ
description We report for the first time that ephedrine alkaloids-free Ephedra Herb extract (EFE) directly inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro and that the addition of EFE to the culture medium before viral infection reduces virus titers in the culture supernatant of SARS-CoV-2, including those of variant strains, by more than 99%, 24 h after infection. The addition of Ephedra Herb macromolecule condensed-tannin, which is the main active ingredient responsible for the anticancer, pain suppression, and anti-influenza effects of EFE, similarly suppressed virus production in the culture supernatant by 99% before infection and by more than 90% after infection. Since EFE does not have the side effects caused by ephedrine alkaloids, such as hypertension, palpitations, and insomnia, our results showed the potential of EFE as a safe therapeutic agent against coronavirus disease 2019.
first_indexed 2024-03-11T08:22:59Z
format Article
id doaj.art-47a5d1fc003d46b9b5617d4556054a4c
institution Directory Open Access Journal
issn 2076-2607
language English
last_indexed 2024-03-11T08:22:59Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Microorganisms
spelling doaj.art-47a5d1fc003d46b9b5617d4556054a4c2023-11-16T22:17:13ZengMDPI AGMicroorganisms2076-26072023-02-0111253410.3390/microorganisms11020534Antiviral Effect of Ephedrine Alkaloids-Free Ephedra Herb Extract against SARS-CoV-2 In VitroMasashi Uema0Masashi Hyuga1Kenzo Yonemitsu2Sumiko Hyuga3Yoshiaki Amakura4Nahoko Uchiyama5Kazushige Mizoguchi6Hiroshi Odaguchi7Yukihiro Goda8National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki 210-9501, Kanagawa, JapanNational Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki 210-9501, Kanagawa, JapanNational Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayama 208-0011, Tokyo, JapanOriental Medicine Research Center, Kitasato University, 5–9-1 Shirokane, Minato-ku, Tokyo 108-8642, JapanCollege of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama 790-8578, Ehime, JapanNational Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki 210-9501, Kanagawa, JapanKampo Research & Development Division, Tsumura & Co., 3586 Yoshiwara, Ami-machi, Inashiki-gun 300-1192, Ibaraki, JapanOriental Medicine Research Center, Kitasato University, 5–9-1 Shirokane, Minato-ku, Tokyo 108-8642, JapanNational Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki 210-9501, Kanagawa, JapanWe report for the first time that ephedrine alkaloids-free Ephedra Herb extract (EFE) directly inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro and that the addition of EFE to the culture medium before viral infection reduces virus titers in the culture supernatant of SARS-CoV-2, including those of variant strains, by more than 99%, 24 h after infection. The addition of Ephedra Herb macromolecule condensed-tannin, which is the main active ingredient responsible for the anticancer, pain suppression, and anti-influenza effects of EFE, similarly suppressed virus production in the culture supernatant by 99% before infection and by more than 90% after infection. Since EFE does not have the side effects caused by ephedrine alkaloids, such as hypertension, palpitations, and insomnia, our results showed the potential of EFE as a safe therapeutic agent against coronavirus disease 2019.https://www.mdpi.com/2076-2607/11/2/534ephedrine alkaloids-free Ephedra Herb extractEphedra Herb macromolecule condensed–tanninCOVID-19SARS-CoV-2antiviral therapeutic
spellingShingle Masashi Uema
Masashi Hyuga
Kenzo Yonemitsu
Sumiko Hyuga
Yoshiaki Amakura
Nahoko Uchiyama
Kazushige Mizoguchi
Hiroshi Odaguchi
Yukihiro Goda
Antiviral Effect of Ephedrine Alkaloids-Free Ephedra Herb Extract against SARS-CoV-2 In Vitro
Microorganisms
ephedrine alkaloids-free Ephedra Herb extract
Ephedra Herb macromolecule condensed–tannin
COVID-19
SARS-CoV-2
antiviral therapeutic
title Antiviral Effect of Ephedrine Alkaloids-Free Ephedra Herb Extract against SARS-CoV-2 In Vitro
title_full Antiviral Effect of Ephedrine Alkaloids-Free Ephedra Herb Extract against SARS-CoV-2 In Vitro
title_fullStr Antiviral Effect of Ephedrine Alkaloids-Free Ephedra Herb Extract against SARS-CoV-2 In Vitro
title_full_unstemmed Antiviral Effect of Ephedrine Alkaloids-Free Ephedra Herb Extract against SARS-CoV-2 In Vitro
title_short Antiviral Effect of Ephedrine Alkaloids-Free Ephedra Herb Extract against SARS-CoV-2 In Vitro
title_sort antiviral effect of ephedrine alkaloids free ephedra herb extract against sars cov 2 in vitro
topic ephedrine alkaloids-free Ephedra Herb extract
Ephedra Herb macromolecule condensed–tannin
COVID-19
SARS-CoV-2
antiviral therapeutic
url https://www.mdpi.com/2076-2607/11/2/534
work_keys_str_mv AT masashiuema antiviraleffectofephedrinealkaloidsfreeephedraherbextractagainstsarscov2invitro
AT masashihyuga antiviraleffectofephedrinealkaloidsfreeephedraherbextractagainstsarscov2invitro
AT kenzoyonemitsu antiviraleffectofephedrinealkaloidsfreeephedraherbextractagainstsarscov2invitro
AT sumikohyuga antiviraleffectofephedrinealkaloidsfreeephedraherbextractagainstsarscov2invitro
AT yoshiakiamakura antiviraleffectofephedrinealkaloidsfreeephedraherbextractagainstsarscov2invitro
AT nahokouchiyama antiviraleffectofephedrinealkaloidsfreeephedraherbextractagainstsarscov2invitro
AT kazushigemizoguchi antiviraleffectofephedrinealkaloidsfreeephedraherbextractagainstsarscov2invitro
AT hiroshiodaguchi antiviraleffectofephedrinealkaloidsfreeephedraherbextractagainstsarscov2invitro
AT yukihirogoda antiviraleffectofephedrinealkaloidsfreeephedraherbextractagainstsarscov2invitro